U.S. High Growth Tech and AI Stocks

Ascendis Pharma

Market Cap: US$8.6b

A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Travere Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Alnylam Pharmaceuticals

Market Cap: US$30.8b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

AVITA Medical

Market Cap: US$227.9m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Alkami Technology

Market Cap: US$2.5b

Provides cloud-based digital banking solutions in the United States.

Lumentum Holdings

Market Cap: US$3.5b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

TG Therapeutics

Market Cap: US$5.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Arcutis Biotherapeutics

Market Cap: US$1.5b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

TKO Group Holdings

Market Cap: US$24.7b

Operates as a sports and entertainment company.

Super Micro Computer

Market Cap: US$19.7b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Clene

Market Cap: US$26.0m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Applied Optoelectronics

Market Cap: US$588.9m

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

Alvotech

Market Cap: US$2.5b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Blueprint Medicines

Market Cap: US$5.2b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Palantir Technologies

Market Cap: US$207.8b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Red Cat Holdings

Market Cap: US$496.8m

Provides various products, services, and solutions to the drone industry in the United States.

Bitdeer Technologies Group

Market Cap: US$1.5b

Operates as a technology company for blockchain and computing.

Core Scientific

Market Cap: US$2.1b

Provides digital asset mining services in the United States.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

ARS Pharmaceuticals

Market Cap: US$1.3b

A biopharmaceutical company, develops treatments for severe allergic reactions.

MeiraGTx Holdings

Market Cap: US$410.0m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

RenovoRx

Market Cap: US$28.2m

A clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

Madrigal Pharmaceuticals

Market Cap: US$7.0b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Abeona Therapeutics

Market Cap: US$223.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

DigitalOcean Holdings

Market Cap: US$2.5b

Through its subsidiaries, operates a cloud computing platform in North America, Europe, Asia, and internationally.

Duos Technologies Group

Market Cap: US$54.0m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

SpringWorks Therapeutics

Market Cap: US$2.7b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

UroGen Pharma

Market Cap: US$466.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

ACADIA Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

SideChannel

Market Cap: US$9.0m

SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.

Pagaya Technologies

Market Cap: US$710.8m

A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial institutions and investors in the United States, Israel, the Cayman Islands, and internationally.

Workday

Market Cap: US$60.3b

Provides enterprise cloud applications in the United States and internationally.

TeraWulf

Market Cap: US$859.3m

Operates as a digital asset technology company in the United States.

Exelixis

Market Cap: US$9.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Nutanix

Market Cap: US$15.8b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

Sarepta Therapeutics

Market Cap: US$5.0b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.